PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: XStream Systems, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

XStream Systems, Inc. Introduces the XT250 System - XStream Systems, Inc., a pharmaceutical authentication company, offers their product which can verify drug ingredients and protect our supply chain against adulterated or counterfeit materials
XStream Systems, Inc. Introduces the XT250 System

 

NewswireToday - /newswire/ - Sebastian, FL, United States, 2008/04/10 - XStream Systems, Inc., a pharmaceutical authentication company, offers their product which can verify drug ingredients and protect our supply chain against adulterated or counterfeit materials.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

A pharmaceutical authentication company is now selling equipment which can verify drug ingredients outside of a laboratory. XStream Systems, Inc. offers a unit which can read the molecular structure of medicines without having to open any packaging or break a bottle’s seal.

Named the XT250 System, its underlying technology was originally developed to protect the public from terrorist threats, but has since found its role in the pharmaceutical industry. It can tell if a drug is counterfeit, altered, contaminated, or otherwise different on a molecular level from its intended form.

“This unit is of great benefit when dealing with drugs or ingredients from questionable sources, such as what we’ve seen from China in the recent Heparin incident,” stated John Lundquist, VP of Business Development for XStream Systems. “The fact it can test drugs when they are still in the manufacturer’s packaging makes the system even more valuable to companies trying to keep their outbound shipments clean.”

The XT250 System is currently being used at multiple locations in the pharmaceutical supply network, checking inventories for dangerous products.

About XStream Systems, Inc.

XStream Systems produces next-generation equipment for material identification. Their patented systems are based on Energy-Dispersive X-Ray Diffraction (EDXRD) technology. The company’s XT250™ System enables testing of powders, pills AND entire sealed bottles. The equipment’s superior sample penetration allows the identification of contents inside opaque plastic, cardboard and even metal packaging.

For more information, call 1-800-597-1191, visit securepharmachain.com or securepharmablog.com online.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: XStream Systems, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


XStream Systems, Inc. Introduces the XT250 System

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Michael DeBoer - XStreamSystems.net 
772-646-6260 r.adams[.]xstreamsystems.net
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any XStream Systems, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From XStream Systems, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
Sartorius Announces Expansion of Sartorius Stedim Cellca
Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Intrinsic Executive Search Ltd

Visit  1Click Games





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)